Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression
Cynthia Putri, Timotius Ivan Hariyanto, Joshua Edward Hananto, et al.
Parkinsonism & Related Disorders (2021) Vol. 87, pp. 155-161
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action
Lin Liu, Shuyu Ni, Wei Yan, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101111-101111
Open Access | Times Cited: 112
Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients; A systematic review and meta-analysis
Zhian Salah Ramzi
The American Journal of Emergency Medicine (2021) Vol. 51, pp. 267-279
Open Access | Times Cited: 62
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
Chengxia Kan, Yang Zhang, Fang Han, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 59
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Diabetes Research and Clinical Practice (2021) Vol. 179, pp. 109031-109031
Open Access | Times Cited: 52
Comparing Fear of COVID-19 and Preventive COVID-19 Infection Behaviors Between Iranian and Taiwanese Older People: Early Reaction May Be a Key
Amir H. Pakpour, Chieh-hsiu Liu, Wen‐Li Hou, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 49
Ivermectin and outcomes from Covid‐19 pneumonia: A systematic review and meta‐analysis of randomized clinical trial studies
Timotius Ivan Hariyanto, Devina Adella Halim, Jane Rosalind, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 44
Epilepsy and the risk of severe coronavirus disease 2019 outcomes: A systematic review, meta-analysis, and meta-regression
Yusak Mangara Tua Siahaan, Retno Jayantri Ketaren, Vinson Hartoyo, et al.
Epilepsy & Behavior (2021) Vol. 125, pp. 108437-108437
Open Access | Times Cited: 41
Mortality from coronavirus disease 2019 (Covid-19) in patients with schizophrenia: A systematic review, meta-analysis and meta-regression
Engelberta Pardamean, Waskita Roan, Karina Terry Amartini Iskandar, et al.
General Hospital Psychiatry (2022) Vol. 75, pp. 61-67
Open Access | Times Cited: 30
Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment
Jinyang Zhao, Fan Xia, Xue Jiao, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 8
Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression
Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 40
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis
Ronal Yosua Limen, Rudyanto Sedono, Adhrie Sugiarto, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 3, pp. 425-434
Open Access | Times Cited: 37
A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2
Ramesh V Nathan, Imad Shawa, Inmaculada de la Torre, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 4, pp. 1933-1947
Open Access | Times Cited: 35
Delirium is a good predictor for poor outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression
Timotius Ivan Hariyanto, Cynthia Putri, Joshua Edward Hananto, et al.
Journal of Psychiatric Research (2021) Vol. 142, pp. 361-368
Open Access | Times Cited: 34
SARS-CoV-2 susceptibility and COVID-19 illness course and outcome in people with pre-existing neurodegenerative disorders: systematic review with frequentist and Bayesian meta-analyses
Muhannad Smadi, Melina Kaburis, Youval Schnapper, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 2, pp. 348-361
Open Access | Times Cited: 15
Psychiatric sequelae in COVID-19 survivors: A narrative review
Cynthia Putri, Jessie Arisa, Joshua Edward Hananto, et al.
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 821-829
Open Access | Times Cited: 27
Effects of GLP-1 receptor agonists on arrhythmias and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis
Jinjing Wei, Ruxin Wang, Haowen Ye, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 20
Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression
Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
Diabetes Research and Clinical Practice (2022) Vol. 195, pp. 110205-110205
Open Access | Times Cited: 20
Prevalence and Mortality Risk of Neurological Disorders during the COVID-19 Pandemic: An Umbrella Review of the Current Evidence
Jong Mi Park, Wongi Woo, Sang Chul Lee, et al.
Neuroepidemiology (2023) Vol. 57, Iss. 3, pp. 129-147
Open Access | Times Cited: 11
Mortality rates for Parkinson’s disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020
Cristina García‐Muñoz, Juan‐Carlos Hernández‐Rodríguez, J Rodríguez
Neurología (2025) Vol. 40, Iss. 2, pp. 161-170
Open Access
Parkinson’s disease related mortality: Long-term trends and impact of COVID-19 pandemic waves
Ugo Fedeli, Veronica Casotto, Claudio Barbiellini Amidei, et al.
Parkinsonism & Related Disorders (2022) Vol. 98, pp. 75-77
Open Access | Times Cited: 17
Comparative features and outcomes of major neurological complications of COVID‐19
Ettore Beghi, Elena Moro, Eugenia Irene Davidescu, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 2, pp. 413-433
Open Access | Times Cited: 17
Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry
José Manuel Ramos, Maria D. López‐Carmona, Lidia Cobos-Palacios, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3769-3769
Open Access | Times Cited: 16
Pre-existing neurological conditions and COVID-19 co-infection: Data from systematic reviews, meta-analyses, and scoping reviews
Abhilasha P. Boruah, Kiran T. Thakur, Sachin P. Gadani, et al.
Journal of the Neurological Sciences (2023) Vol. 455, pp. 120858-120858
Open Access | Times Cited: 8
Risk of COVID-19 diagnosis and death in patients with mental illness: a cohort study
Jeong-Yeon Seon, Sunjea Kim, Minha Hong, et al.
Epidemiology and Psychiatric Sciences (2021) Vol. 30
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top